Summary
This 8-K filing from Bristol-Myers Squibb Company (BMY), dated July 24, 2003, primarily serves to report the company's financial results for the second quarter of 2003. The key information for investors is contained within an attached press release (Exhibit 99.1), which details the company's earnings performance for the period. This filing is made under Regulation FD, ensuring that material information about the company's financial condition and results of operations is publicly disclosed in a timely manner.
Key Highlights
- 1Bristol-Myers Squibb Company filed an 8-K Current Report on July 24, 2003.
- 2The report primarily contains financial results for the second quarter of 2003.
- 3Exhibit 99.1 is a press release detailing the company's Q2 2003 earnings.
- 4The filing is made under Regulation FD, ensuring broad public disclosure.
- 5The information provided is being furnished and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly disclose Bristol-Myers Squibb's financial results for the second quarter of 2003, as detailed in an attached press release.
The specific financial results for the second quarter of 2003 are located in Exhibit 99.1, which is a press release issued by Bristol-Myers Squibb Company on July 24, 2003.
No, according to the filing, the information is being 'furnished' under Regulation FD and is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means it is for public disclosure but does not carry the same legal implications as a formally 'filed' document in that specific context.